Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer-A Critical Review and Practical Consideration

P. Burkoň, J. Trna, M. Slávik, R. Němeček, T. Kazda, P. Pospíšil, M. Dastych, M. Eid, I. Novotný, T. Procházka, M. Vrzal

. 2022 ; 10 (10) : . [pub] 20221004

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22031614

Pancreatic cancer is the third leading cause of cancer death in the developed world and is predicted to become the second by 2030. A cure may be achieved only with surgical resection of an early diagnosed disease. Surgery for more advanced disease is challenging and can be contraindicated for many reasons. Neoadjuvant therapy may improve the probability of achieving R0 resection. It consists of systemic treatment followed by radiation therapy applied concurrently or sequentially with cytostatics. A novel approach to irradiation, stereotactic body radiotherapy (SBRT), has the potential to improve treatment results. SBRT can deliver higher doses of radiation to the tumor in only a few treatment fractions. It has attracted significant interest for pancreatic cancer patients, as it is completed quickly, requires less time away from full-dose chemotherapy, and is well-tolerated than conventional radiotherapy. In this review, we aim to provide the reader with a basic overview of current evidence for SBRT indications in the treatment of pancreatic tumors. In the second part of the review, we focus on practical information with respect to SBRT treatment plan preparation the performance of such therapy. Finally, we discuss future directions related to the use of magnetic resonance linear accelerators.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22031614
003      
CZ-PrNML
005      
20230127131235.0
007      
ta
008      
230119s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/biomedicines10102480 $2 doi
035    __
$a (PubMed)36289742
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Burkoň, Petr $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Zluty Kopec 7, 656 57 Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Kamenice 753/5, 625 00 Brno, Czech Republic $1 https://orcid.org/0000000298639376
245    10
$a Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer-A Critical Review and Practical Consideration / $c P. Burkoň, J. Trna, M. Slávik, R. Němeček, T. Kazda, P. Pospíšil, M. Dastych, M. Eid, I. Novotný, T. Procházka, M. Vrzal
520    9_
$a Pancreatic cancer is the third leading cause of cancer death in the developed world and is predicted to become the second by 2030. A cure may be achieved only with surgical resection of an early diagnosed disease. Surgery for more advanced disease is challenging and can be contraindicated for many reasons. Neoadjuvant therapy may improve the probability of achieving R0 resection. It consists of systemic treatment followed by radiation therapy applied concurrently or sequentially with cytostatics. A novel approach to irradiation, stereotactic body radiotherapy (SBRT), has the potential to improve treatment results. SBRT can deliver higher doses of radiation to the tumor in only a few treatment fractions. It has attracted significant interest for pancreatic cancer patients, as it is completed quickly, requires less time away from full-dose chemotherapy, and is well-tolerated than conventional radiotherapy. In this review, we aim to provide the reader with a basic overview of current evidence for SBRT indications in the treatment of pancreatic tumors. In the second part of the review, we focus on practical information with respect to SBRT treatment plan preparation the performance of such therapy. Finally, we discuss future directions related to the use of magnetic resonance linear accelerators.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Trna, Jan $u Faculty of Medicine, Masaryk University, Kamenice 753/5, 625 00 Brno, Czech Republic $u Department of Gastroenterology and Digestive Endoscopy, Masaryk Memorial Cancer Institute, Zluty Kopec 7, 656 53 Brno, Czech Republic $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Zluty Kopec 7, 656 53 Brno, Czech Republic $1 https://orcid.org/0000000331389736
700    1_
$a Slávik, Marek $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Zluty Kopec 7, 656 57 Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Kamenice 753/5, 625 00 Brno, Czech Republic $1 https://orcid.org/0000000285915941
700    1_
$a Němeček, Radim $u Faculty of Medicine, Masaryk University, Kamenice 753/5, 625 00 Brno, Czech Republic $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Zluty Kopec 7, 656 53 Brno, Czech Republic
700    1_
$a Kazda, Tomáš $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Zluty Kopec 7, 656 57 Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Kamenice 753/5, 625 00 Brno, Czech Republic $1 https://orcid.org/0000000172888975
700    1_
$a Pospíšil, Petr $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Zluty Kopec 7, 656 57 Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Kamenice 753/5, 625 00 Brno, Czech Republic
700    1_
$a Dastych, Milan $u Faculty of Medicine, Masaryk University, Kamenice 753/5, 625 00 Brno, Czech Republic $u Department of Gastroenterology, University Hospital Brno, Jihlavska 340/20, 625 00 Brno, Czech Republic
700    1_
$a Eid, Michal $u Faculty of Medicine, Masaryk University, Kamenice 753/5, 625 00 Brno, Czech Republic $u Department of Hematology, Oncology and Internal Medicine, University Hospital Brno, Jihlavska 340/20, 625 00 Brno, Czech Republic $1 https://orcid.org/0000000244335326
700    1_
$a Novotný, Ivo $u Department of Gastroenterology and Digestive Endoscopy, Masaryk Memorial Cancer Institute, Zluty Kopec 7, 656 53 Brno, Czech Republic
700    1_
$a Procházka, Tomáš $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Zluty Kopec 7, 656 57 Brno, Czech Republic $u Faculty of Medicine, Masaryk University, Kamenice 753/5, 625 00 Brno, Czech Republic
700    1_
$a Vrzal, Miroslav $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute, Zluty Kopec 7, 656 57 Brno, Czech Republic
773    0_
$w MED00205373 $t Biomedicines $x 2227-9059 $g Roč. 10, č. 10 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36289742 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230119 $b ABA008
991    __
$a 20230127131227 $b ABA008
999    __
$a ok $b bmc $g 1889572 $s 1182947
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2022 $b 10 $c 10 $e 20221004 $i 2227-9059 $m Biomedicines $n Biomedicines $x MED00205373
LZP    __
$a Pubmed-20230119

Najít záznam

Citační ukazatele

Možnosti archivace